Ajay Ohri of The Alka Ohri Foundation
Bridgewater, NJ - A 2018 analysis by Clinical and Translational Medicine of chemotherapies shows failure rates of 90% (±5). While chemotherapy has been proven to prolong the life of cancer patients, chemotherapy is very hard on the patient and not a cure. Ajay Ohri of The Alka Ohri Foundation experienced these statistics when his wife, Alka, was diagnosed with Metastatic Triple Negative Breast Cancer (MTNBC HER2–), which accounts for 10 to 20% of all breast cancer cases.
“When my wife was first diagnosed, not knowing what to do, even with my background in pharmaceuticals, we went with the flow and she started taking chemo.”
“A year later, Alka was still with us but suffering from the side effects of chemo and radiation. Not until her stage of cancer went from one to three in one month and the cancer had metastasized in her lungs did we begin learning about the holistic side of cancer treatment. Alka began meditating, exercising, and practicing yoga,” shares Ajay.
“The Alka Ohri Foundation is working on a program to put all of these variables in place,” explains Ajay. “We are currently working with the Dana-Farber Cancer Institute and Sloan-Kettering, who are each looking at 50 cancer patients on chemo and as well as holistic therapies. These patients will receive yoga training, work with an oncology nutritionist, and other holistic therapies. After the 12-month studies, the resulting programs will be phenomenal.
“I don’t want any woman to suffer the way my Alka suffered,” shares Ajay.
For more information about Ajay K. Ohri, please visit https://www.alkaohri.org/